{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T17:28:22Z","timestamp":1788888502470,"version":"build-2803163510"},"reference-count":65,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001332","name":"CSIR","doi-asserted-by":"crossref","award":["BSC0115"],"award-info":[{"award-number":["BSC0115"]}],"id":[{"id":"10.13039\/501100001332","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurochemistry International"],"published-print":{"date-parts":[[2016,1]]},"DOI":"10.1016\/j.neuint.2015.11.006","type":"journal-article","created":{"date-parts":[[2015,12,2]],"date-time":"2015-12-02T06:20:13Z","timestamp":1449037213000},"page":"25-34","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":48,"special_numbering":"C","title":["Neuroprotective effects of caffeine in MPTP model of Parkinson's disease: A 13 C NMR study"],"prefix":"10.1016","volume":"92","author":[{"given":"Puneet","family":"Bagga","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4908-7720","authenticated-orcid":false,"given":"Anup N.","family":"Chugani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anant B.","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.neuint.2015.11.006_bib1","doi-asserted-by":"crossref","first-page":"809","DOI":"10.2174\/0929867013372995","article-title":"Parkinson's disease\u2013redox mechanisms","volume":"8","author":"Adams","year":"2001","journal-title":"Curr. Med. Chem."},{"issue":"3","key":"10.1016\/j.neuint.2015.11.006_bib2","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.pbb.2006.05.027","article-title":"Neuroprotective effects of caffeine in the model of 6-hydroxydopamine lesion in rats","volume":"84","author":"Aguiar","year":"2006","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"10","key":"10.1016\/j.neuint.2015.11.006_bib3","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1038\/nn.2916","article-title":"Engrailed protects mouse midbrain dopaminergic neurons against mitochondrial complex I insults","volume":"14","author":"Alvarez-Fischer","year":"2011","journal-title":"Nat. Neurosci."},{"issue":"1","key":"10.1016\/j.neuint.2015.11.006_bib4","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1002\/ana.1052","article-title":"Prospective study of caffeine consumption and risk of Parkinson's disease in men and women","volume":"50","author":"Ascherio","year":"2001","journal-title":"Ann. Neurol."},{"issue":"2","key":"10.1016\/j.neuint.2015.11.006_bib5","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.neuint.2011.10.016","article-title":"Regional cerebral metabolism in mouse under chronic manganese exposure: implications for manganism","volume":"60","author":"Bagga","year":"2012","journal-title":"Neurochem. Int."},{"issue":"3","key":"10.1016\/j.neuint.2015.11.006_bib6","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1111\/jnc.12407","article-title":"In\u00a0vivo NMR studies of regional cerebral energetics in MPTP model of Parkinson's disease: recovery of cerebral metabolism with acute levodopa treatment","volume":"127","author":"Bagga","year":"2013","journal-title":"J.\u00a0Neurochem."},{"issue":"1","key":"10.1016\/j.neuint.2015.11.006_bib7","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/BF00613933","article-title":"The absolute bioavailability of caffeine in man","volume":"24","author":"Blanchard","year":"1983","journal-title":"Eur. J. Clin. Pharmacol."},{"issue":"1","key":"10.1016\/j.neuint.2015.11.006_bib8","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1038\/clpt.1982.132","article-title":"Caffeine disposition after oral doses","volume":"32","author":"Bonati","year":"1982","journal-title":"Clin. Pharmacol. Ther."},{"issue":"7","key":"10.1016\/j.neuint.2015.11.006_bib9","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.3109\/03602538409029964","article-title":"Interspecies comparison of in\u00a0vivo caffeine pharmacokinetics in man, monkey, rabbit, rat, and mouse","volume":"15","author":"Bonati","year":"1984","journal-title":"Drug Metab. Rev."},{"issue":"1\u20132","key":"10.1016\/j.neuint.2015.11.006_bib10","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.jns.2011.09.010","article-title":"Cerebral oxygen metabolism in patients with early Parkinson's disease","volume":"313","author":"Borghammer","year":"2012","journal-title":"J.\u00a0Neurol. Sci."},{"issue":"3","key":"10.1016\/j.neuint.2015.11.006_bib11","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1007\/s11481-013-9460-x","article-title":"Magnetic resonance spectroscopy to assess neuroinflammation and neuropathic pain","volume":"8","author":"Chang","year":"2013","journal-title":"J.\u00a0Neuroimmune Pharmacol."},{"issue":"4","key":"10.1016\/j.neuint.2015.11.006_bib12","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1111\/j.1471-4159.2008.05697.x","article-title":"Caffeine protects against MPTP-induced blood-brain barrier dysfunction in mouse striatum","volume":"107","author":"Chen","year":"2008","journal-title":"J.\u00a0Neurochem."},{"issue":"Suppl.\u00a01","key":"10.1016\/j.neuint.2015.11.006_bib13","doi-asserted-by":"crossref","first-page":"S221","DOI":"10.3233\/JAD-2010-091525","article-title":"Caffeine exposure and the risk of Parkinson's disease: a systematic review and meta-analysis of observational studies","volume":"20","author":"Costa","year":"2010","journal-title":"J.\u00a0Alzheimers Dis."},{"issue":"1","key":"10.1016\/j.neuint.2015.11.006_bib14","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1002\/nbm.2817","article-title":"An in\u00a0vivo ultrahigh field 14.1 T 1H-MRS study on 6-OHDA and alpha-synuclein-based rat models of Parkinson's disease: GABA as an early disease marker","volume":"26","author":"Coune","year":"2013","journal-title":"NMR Biomed."},{"issue":"6","key":"10.1016\/j.neuint.2015.11.006_bib15","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/nrneurol.2012.80","article-title":"Olfactory dysfunction in Parkinson disease","volume":"8","author":"Doty","year":"2012","journal-title":"Nat. Rev. Neurol."},{"issue":"1","key":"10.1016\/j.neuint.2015.11.006_bib16","doi-asserted-by":"crossref","first-page":"e30918","DOI":"10.1371\/journal.pone.0030918","article-title":"Elevated pontine and putamenal GABA levels in mild-moderate Parkinson disease detected by 7 tesla proton MRS","volume":"7","author":"Emir","year":"2012","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.neuint.2015.11.006_bib17","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/jcbfm.1990.32","article-title":"The flux from glucose to glutamate in the rat brain in\u00a0vivo as determined by 1H-observed, 13C-edited NMR spectroscopy","volume":"10","author":"Fitzpatrick","year":"1990","journal-title":"J.\u00a0Cereb. Blood Flow. Metab."},{"issue":"1","key":"10.1016\/j.neuint.2015.11.006_bib18","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0031-6997(24)01396-6","article-title":"Actions of caffeine in the brain with special reference to factors that contribute to its widespread use","volume":"51","author":"Fredholm","year":"1999","journal-title":"Pharmacol. Rev."},{"issue":"1","key":"10.1016\/j.neuint.2015.11.006_bib19","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0361-9230(01)00501-9","article-title":"Caffeine reverses the memory disruption induced by intra-nigral MPTP-injection in rats","volume":"55","author":"Gevaerd","year":"2001","journal-title":"Brain Res. Bull."},{"issue":"2","key":"10.1016\/j.neuint.2015.11.006_bib20","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0197-0186(02)00225-5","article-title":"Deficits in a tricarboxylic acid cycle enzyme in brains from patients with Parkinson's disease","volume":"43","author":"Gibson","year":"2003","journal-title":"Neurochem. Int."},{"issue":"6\u20137","key":"10.1016\/j.neuint.2015.11.006_bib21","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1002\/nbm.847","article-title":"In\u00a0vivo 1H-[13C]-NMR spectroscopy of cerebral metabolism","volume":"16","author":"de Graaf","year":"2003","journal-title":"NMR Biomed."},{"key":"10.1016\/j.neuint.2015.11.006_bib22","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1002\/mrm.10348","article-title":"Detection of [1,6\u201313C2]-glucose metabolism in rat brain by in\u00a0vivo 1H-[13C]-NMR spectroscopy","volume":"49","author":"de Graaf","year":"2003","journal-title":"Magn. Reson Med."},{"issue":"2","key":"10.1016\/j.neuint.2015.11.006_bib23","article-title":"Two wrongs make a right: nicotine and caffeine as defensive agents against Parkinson's disease","volume":"8","author":"Ho","year":"2002","journal-title":"Nutr. Bytes"},{"issue":"1","key":"10.1016\/j.neuint.2015.11.006_bib24","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/j.1552-6569.2011.00663.x","article-title":"Functional imaging of the cerebellum and basal ganglia during predictive motor timing in early Parkinson's disease","volume":"24","author":"Husarova","year":"2011","journal-title":"J.\u00a0Neuroimag."},{"issue":"7","key":"10.1016\/j.neuint.2015.11.006_bib25","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1038\/sj.jcbfm.9600263","article-title":"Neuronal-glial glucose oxidation and glutamatergic-GABAergic function","volume":"26","author":"Hyder","year":"2006","journal-title":"J.\u00a0Cereb. Blood Flow. Metab."},{"issue":"Suppl.\u00a03","key":"10.1016\/j.neuint.2015.11.006_bib26","doi-asserted-by":"crossref","first-page":"S26","DOI":"10.1002\/ana.10483","article-title":"Oxidative stress in Parkinson's disease","volume":"53","author":"Jenner","year":"2003","journal-title":"Ann. Neurol."},{"issue":"Suppl.\u00a04","key":"10.1016\/j.neuint.2015.11.006_bib27","doi-asserted-by":"crossref","first-page":"S18","DOI":"10.1016\/S1353-8020(09)70829-6","article-title":"From the MPTP-treated primate to the treatment of motor complications in Parkinson's disease","volume":"15","author":"Jenner","year":"2009","journal-title":"Park. Relat. Disord."},{"issue":"42","key":"10.1016\/j.neuint.2015.11.006_bib28","doi-asserted-by":"crossref","first-page":"17010","DOI":"10.1073\/pnas.1213956109","article-title":"Neuroprotective efficacy of aminopropyl carbazoles in a mouse model of Parkinson disease","volume":"109","author":"De Jesus-Cortes","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"8","key":"10.1016\/j.neuint.2015.11.006_bib29","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.parkreldis.2004.06.004","article-title":"Protective effect of caffeine against neurodegeneration in a model of Parkinson's disease in rat: behavioral and histochemical evidence","volume":"10","author":"Joghataie","year":"2004","journal-title":"Park. Relat. Disord."},{"issue":"2","key":"10.1016\/j.neuint.2015.11.006_bib30","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.expneurol.2010.02.007","article-title":"Caffeine protects against combined paraquat and maneb-induced dopaminergic neuron degeneration","volume":"223","author":"Kachroo","year":"2010","journal-title":"Exp. Neurol."},{"issue":"3","key":"10.1016\/j.neuint.2015.11.006_bib31","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1111\/j.1476-5381.1990.tb15824.x","article-title":"Caffeine-induced behavioural stimulation is dose- and concentration-dependent","volume":"100","author":"Kaplan","year":"1990","journal-title":"Br. J. Pharmacol."},{"issue":"3","key":"10.1016\/j.neuint.2015.11.006_bib32","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0162-3109(98)00022-8","article-title":"Microglial and astrocytic involvement in a murine model of Parkinson's disease induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)","volume":"39","author":"Kohutnicka","year":"1998","journal-title":"Immunopharmacology"},{"issue":"5","key":"10.1016\/j.neuint.2015.11.006_bib33","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1002\/ana.410150504","article-title":"Patterns of local cerebral glucose utilization determined in Parkinson's disease by the [18F]fluorodeoxyglucose method","volume":"15","author":"Kuhl","year":"1984","journal-title":"Ann. Neurol."},{"issue":"6109","key":"10.1016\/j.neuint.2015.11.006_bib34","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1126\/science.1227157","article-title":"Pathological alpha-synuclein transmission initiates Parkinson-like neurodegeneration in nontransgenic mice","volume":"338","author":"Luk","year":"2012","journal-title":"Science"},{"key":"10.1016\/j.neuint.2015.11.006_bib35","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.bbr.2014.01.051","article-title":"Caffeine neuroprotective effects on 6-OHDA-lesioned rats are mediated by several factors, including pro-inflammatory cytokines and histone deacetylase inhibitions","volume":"264","author":"Machado-Filho","year":"2014","journal-title":"Behav. Brain Res."},{"issue":"1","key":"10.1016\/j.neuint.2015.11.006_bib36","first-page":"19","article-title":"MPTP mouse models of Parkinson's disease: an update","volume":"1","author":"Meredith","year":"2011","journal-title":"J.\u00a0Park. Dis."},{"issue":"2","key":"10.1016\/j.neuint.2015.11.006_bib37","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.jns.2006.06.018","article-title":"Enhanced neuroprotective effect by combination of bromocriptine and Hypericum perforatum extract against MPTP-induced neurotoxicity in mice","volume":"249","author":"Mohanasundari","year":"2006","journal-title":"J.\u00a0Neurol. Sci."},{"issue":"193","key":"10.1016\/j.neuint.2015.11.006_bib38","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1007\/978-3-540-89615-9_18","article-title":"Adenosine A2A receptors and Parkinson's disease","author":"Morelli","year":"2009","journal-title":"Handb. Exp. Pharmacol."},{"issue":"4","key":"10.1016\/j.neuint.2015.11.006_bib39","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1212\/WNL.46.4.1044","article-title":"Epidemiologic observations on Parkinson's disease: incidence and mortality in a prospective study of middle-aged men","volume":"46","author":"Morens","year":"1996","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.neuint.2015.11.006_bib40","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/S0149-7634(98)00050-5","article-title":"Are we dependent upon coffee and caffeine? A review on human and animal data","volume":"23","author":"Nehlig","year":"1999","journal-title":"Neurosci. Biobehav Rev."},{"issue":"5","key":"10.1016\/j.neuint.2015.11.006_bib41","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1111\/j.1471-4159.1991.tb02062.x","article-title":"Cerebral metabolic effects of monoamine oxidase inhibition in normal and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine acutely treated monkeys","volume":"56","author":"Palombo","year":"1991","journal-title":"J.\u00a0Neurochem."},{"issue":"2","key":"10.1016\/j.neuint.2015.11.006_bib42","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S0006-8993(01)03015-3","article-title":"Glutamine is the major precursor for GABA synthesis in rat neocortex in\u00a0vivo following acute GABA-transaminase inhibition","volume":"919","author":"Patel","year":"2001","journal-title":"Brain Res."},{"issue":"9","key":"10.1016\/j.neuint.2015.11.006_bib43","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1097\/01.WCB.0000126234.16188.71","article-title":"Glutamatergic neurotransmission and neuronal glucose oxidation are coupled during intense neuronal activation","volume":"24","author":"Patel","year":"2004","journal-title":"J.\u00a0Cereb. Blood Flow. Metab."},{"issue":"15","key":"10.1016\/j.neuint.2015.11.006_bib44","doi-asserted-by":"crossref","first-page":"5588","DOI":"10.1073\/pnas.0501703102","article-title":"The contribution of GABA to glutamate\/glutamine cycling and energy metabolism in the rat cortex in\u00a0vivo","volume":"102","author":"Patel","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"4","key":"10.1016\/j.neuint.2015.11.006_bib45","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/nrneurol.2010.17","article-title":"Microglia in neurodegenerative disease","volume":"6","author":"Perry","year":"2010","journal-title":"Nat. Rev. Neurol."},{"issue":"4","key":"10.1016\/j.neuint.2015.11.006_bib46","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.neuropharm.2004.11.009","article-title":"KW-6002 protects from MPTP induced dopaminergic toxicity in the mouse","volume":"48","author":"Pierri","year":"2005","journal-title":"Neuropharmacology"},{"issue":"Suppl.\u00a01","key":"10.1016\/j.neuint.2015.11.006_bib47","doi-asserted-by":"crossref","first-page":"S205","DOI":"10.3233\/JAD-2010-091459","article-title":"Effects of caffeine in Parkinson's disease: from neuroprotection to the management of motor and non-motor symptoms","volume":"20","author":"Prediger","year":"2010","journal-title":"J.\u00a0Alzheimers Dis."},{"issue":"4","key":"10.1016\/j.neuint.2015.11.006_bib48","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/j.neuroscience.2005.01.014","article-title":"Different synaptic and subsynaptic localization of adenosine A2A receptors in the hippocampus and striatum of the rat","volume":"132","author":"Rebola","year":"2005","journal-title":"Neuroscience"},{"issue":"20","key":"10.1016\/j.neuint.2015.11.006_bib49","doi-asserted-by":"crossref","first-page":"2674","DOI":"10.1001\/jama.283.20.2674","article-title":"Association of coffee and caffeine intake with the risk of Parkinson disease","volume":"283","author":"Ross","year":"2000","journal-title":"Jama"},{"key":"10.1016\/j.neuint.2015.11.006_bib50","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1146\/annurev.physiol.65.092101.142131","article-title":"In\u00a0vivo NMR studies of the glutamate neurotransmitter flux and neuroenergetics: implications for brain function","volume":"65","author":"Rothman","year":"2003","journal-title":"Annu. Rev. Physiol."},{"issue":"6","key":"10.1016\/j.neuint.2015.11.006_bib51","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1111\/j.1460-9568.1996.tb01294.x","article-title":"The extraneuronal transporter for monoamine transmitters exists in cells derived from human central nervous system glia","volume":"8","author":"Russ","year":"1996","journal-title":"Eur. J. Neurosci."},{"issue":"11","key":"10.1016\/j.neuint.2015.11.006_bib52","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1007\/s007020100004","article-title":"Neurochemical findings in the MPTP model of Parkinson's disease","volume":"108","author":"Schmidt","year":"2001","journal-title":"J.\u00a0Neural Transm."},{"issue":"1","key":"10.1016\/j.neuint.2015.11.006_bib53","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1073\/pnas.95.1.316","article-title":"Stoichiometric coupling of brain glucose metabolism and glutamatergic neuronal activity","volume":"95","author":"Sibson","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuint.2015.11.006_bib54","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.brainres.2009.06.002","article-title":"Effect of caffeine on the expression of cytochrome P450 1A2, adenosine A2A receptor and dopamine transporter in control and 1-methyl 4-phenyl 1, 2, 3, 6-tetrahydropyridine treated mouse striatum","volume":"1283","author":"Singh","year":"2009","journal-title":"Brain Res."},{"issue":"7","key":"10.1016\/j.neuint.2015.11.006_bib55","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1038\/jcbfm.2013.54","article-title":"Brain mitochondrial metabolic dysfunction and glutamate level reduction in the pilocarpine model of temporal lobe epilepsy in mice","volume":"33","author":"Smeland","year":"2013","journal-title":"J.\u00a0Cereb. Blood Flow. Metab."},{"issue":"1","key":"10.1016\/j.neuint.2015.11.006_bib56","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.molbrainres.2004.09.017","article-title":"The MPTP model of Parkinson's disease","volume":"134","author":"Smeyne","year":"2005","journal-title":"Brain Res. Mol. Brain Res."},{"issue":"12","key":"10.1016\/j.neuint.2015.11.006_bib57","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1002\/hbm.20987","article-title":"Basal ganglia hypoactivity during grip force in drug naive Parkinson's disease","volume":"31","author":"Spraker","year":"2010","journal-title":"Hum. Brain Mapp."},{"issue":"2","key":"10.1016\/j.neuint.2015.11.006_bib58","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1002\/mds.10332","article-title":"Pathogenic role of glial cells in Parkinson's disease","volume":"18","author":"Teismann","year":"2003","journal-title":"Mov. Disord. official J. Mov. Disord. Soc."},{"issue":"10","key":"10.1016\/j.neuint.2015.11.006_bib59","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1038\/jcbfm.2013.114","article-title":"Glutamatergic and GABAergic TCA cycle and neurotransmitter cycling fluxes in different regions of mouse brain","volume":"33","author":"Tiwari","year":"2013","journal-title":"J.\u00a0Cereb. Blood Flow. Metab."},{"issue":"5","key":"10.1016\/j.neuint.2015.11.006_bib60","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1111\/jnc.12508","article-title":"Differential effects of ethanol on regional glutamatergic and GABAergic neurotransmitter pathways in mouse brain","volume":"128","author":"Tiwari","year":"2014","journal-title":"J.\u00a0Neurochem."},{"issue":"3","key":"10.1016\/j.neuint.2015.11.006_bib61","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.biopsych.2013.09.024","article-title":"Dysfunctional glutamatergic and gamma-aminobutyric acidergic activities in prefrontal cortex of mice in social defeat model of depression","volume":"76","author":"Veeraiah","year":"2014","journal-title":"Biol. Psychiatry"},{"issue":"5","key":"10.1016\/j.neuint.2015.11.006_bib62","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1111\/ggi.12321","article-title":"Macronutrients intake and risk of Parkinson's disease: a meta-analysis","volume":"15","author":"Wang","year":"2015","journal-title":"Geriatr. Gerontol. Int."},{"issue":"2","key":"10.1016\/j.neuint.2015.11.006_bib63","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.neuroscience.2010.02.020","article-title":"Neuroprotection by caffeine: time course and role of its metabolites in the MPTP model of Parkinson's disease","volume":"167","author":"Xu","year":"2010","journal-title":"Neuroscience"},{"issue":"7\u20138","key":"10.1016\/j.neuint.2015.11.006_bib64","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1080\/1029842021000045507","article-title":"Early and late molecular events in neurodegeneration and neuroprotection in Parkinson's disease MPTP model as assessed by cDNA microarray; the role of iron","volume":"4","author":"Youdim","year":"2002","journal-title":"Neurotox. Res."},{"issue":"Suppl.\u00a01","key":"10.1016\/j.neuint.2015.11.006_bib65","doi-asserted-by":"crossref","first-page":"S60","DOI":"10.1016\/S1353-8020(11)70020-7","article-title":"18F-FDG PET study on the idiopathic Parkinson's disease from several parkinsonian-plus syndromes","volume":"18","author":"Zhao","year":"2012","journal-title":"Park. Relat. Disord."}],"container-title":["Neurochemistry International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197018615300693?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197018615300693?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,31]],"date-time":"2025-05-31T16:49:19Z","timestamp":1748710159000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0197018615300693"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1]]},"references-count":65,"alternative-id":["S0197018615300693"],"URL":"https:\/\/doi.org\/10.1016\/j.neuint.2015.11.006","relation":{},"ISSN":["0197-0186"],"issn-type":[{"value":"0197-0186","type":"print"}],"subject":[],"published":{"date-parts":[[2016,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neuroprotective effects of caffeine in MPTP model of Parkinson's disease: A 13C NMR study","name":"articletitle","label":"Article Title"},{"value":"Neurochemistry International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuint.2015.11.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}